After the patient imbibes the new protein, called iRFP, a shot of near-infrared light induces the protein to emit its own powerful light that can be picked up by a scanner. Researchers have been experimenting with the protein on mice.
Use of iRFP would allow physicians to noninvasively monitor the growth of tumors and assess the effectiveness of anti-cancer therapies.
Read the Albert Einstein College of Medicine release on fluorescent protein imaging.
Related Articles on Imaging:
Philips Launches Custom Service Contracts for Imaging Equipment
GE Launches Three New Mobile X-Ray Systems
Recent Isotope Shortages Spur Alternative Imaging Technologies
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.